학술논문

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
Document Type
Journal
Source
CANCER CHEMOTHERAPY AND PHARMACOLOGY; NOV 13 2021, 11p.
Subject
Language
English
ISSN
14320843